Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real‐World Multicentre Study in Japan

ABSTRACT Background Three Janus kinase (JAK) inhibitors are approved for ulcerative colitis (UC) in Japan. Aim To compare the real‐world efficacy and safety of these three JAK inhibitors in UC. Methods This was a multicentre, retrospective study of patients with UC started on JAK inhibitors. The pri...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alimentary pharmacology & therapeutics 2024-11, Vol.61 (3), p.524-537
Hauptverfasser:	Akiyama, Shintaro, Shimizu, Hiromichi, Tamura, Akiko, Yokoyama, Kaoru, Sakurai, Toshiyuki, Kobayashi, Mariko, Eizuka, Makoto, Yanai, Shunichi, Nomura, Kei, Shibuya, Tomoyoshi, Takahara, Masahiro, Hiraoka, Sakiko, Sako, Minako, Yoshida, Atsushi, Tsuruta, Kozo, Yoshioka, Shinichiro, Koroku, Miki, Omori, Teppei, Saruta, Masayuki, Matsumoto, Takayuki, Okamoto, Ryuichi, Tsuchiya, Kiichiro, Fujii, Toshimitsu
Format:	Artikel
Sprache:	eng
Schlagworte:	Acne Comparative analysis Enzyme inhibitors filgotinib Inflammatory bowel disease Janus kinase Multivariate analysis Remission Remission (Medicine) tofacitinib Ulcerative colitis upadacitinib
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!